- Home
- POWW vs TLSI Comparison
POWW vs TLSI Comparison
Compare POWW & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POWW
- TLSI
- Stock Information
- Founded
- POWW 1990
- TLSI 2010
- Country
- POWW United States
- TLSI United States
- Employees
- POWW N/A
- TLSI N/A
- Industry
- POWW Ordnance And Accessories
- TLSI Medical Specialities
- Sector
- POWW Industrials
- TLSI Health Care
- Exchange
- POWW Nasdaq
- TLSI Nasdaq
- Market Cap
- POWW 209.6M
- TLSI 244.3M
- IPO Year
- POWW N/A
- TLSI N/A
- Fundamental
- Price
- POWW $1.72
- TLSI $5.05
- Analyst Decision
- POWW Strong Buy
- TLSI Strong Buy
- Analyst Count
- POWW 2
- TLSI 3
- Target Price
- POWW $2.38
- TLSI $10.67
- AVG Volume (30 Days)
- POWW 465.6K
- TLSI 95.1K
- Earning Date
- POWW 11-10-2025
- TLSI 11-13-2025
- Dividend Yield
- POWW N/A
- TLSI N/A
- EPS Growth
- POWW N/A
- TLSI N/A
- EPS
- POWW N/A
- TLSI N/A
- Revenue
- POWW $46,632,638.00
- TLSI $40,207,000.00
- Revenue This Year
- POWW $10.08
- TLSI $57.25
- Revenue Next Year
- POWW $0.94
- TLSI $54.05
- P/E Ratio
- POWW N/A
- TLSI N/A
- Revenue Growth
- POWW 1343.57
- TLSI 49.52
- 52 Week Low
- POWW $0.95
- TLSI $3.42
- 52 Week High
- POWW $2.14
- TLSI $5.88
- Technical
- Relative Strength Index (RSI)
- POWW 53.05
- TLSI 61.54
- Support Level
- POWW $1.71
- TLSI $3.79
- Resistance Level
- POWW $1.93
- TLSI $4.88
- Average True Range (ATR)
- POWW 0.12
- TLSI 0.36
- MACD
- POWW -0.01
- TLSI 0.06
- Stochastic Oscillator
- POWW 37.50
- TLSI 96.56
About POWW AMMO Inc.
Outdoor Holding Co Formerly AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.